Heat therapy injected into tumors for advanced skin melanoma
Part of Injuries & trauma clinical trials.
This trial tests a new treatment where a tiny gold particle is injected into skin tumors and then heated to destroy cancer cells. It is for people with advanced melanoma that has not responded to standard therapies like immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You have advanced melanoma that has spread to the skin or other parts of the body.
- You have at least one skin tumor between 0.5 and 2.5 cm wide that can be seen and reached with a needle.
- You have already tried immunotherapy and an injected treatment called IL-2, and your cancer did not respond.
- You are not pregnant or breastfeeding, and you can stop blood thinners during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new therapy that uses tiny gold particles to heat and destroy melanoma tumors on the skin or just under the skin. It is for people whose melanoma has spread and has not responded to standard treatments.
This trial tests a new cell therapy made from your own tumor-fighting cells (TILs) for advanced melanoma that hasn't responded to other treatments. It aims to shrink tumors by re-infusing these boosted cells back into your body.
This trial tests whether combining a local treatment that freezes a tumor (cryoablation) with two immune “checkpoint” medicines (ipilimumab and nivolumab) can better control unresectable melanoma. It may help when melanoma has grown after prior immune therapy.
This trial tests whether adding heat therapy (hyperthermia) to radiation therapy works well for older adults with larger non-melanoma skin cancers. It may help shrink tumors without needing surgery.
This trial tests a new combination immunotherapy for people with advanced melanoma. It aims to help those whose cancer has not been controlled by standard treatments.
This study tests a very focused form of radiation for melanoma that has spread and has stopped responding to PD-1 (and sometimes CTLA-4) immunotherapy. It may help by shrinking progressing spots while keeping the immune treatment going.
Hear when a new Cutaneous Metastatic Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.